Drug interactions
Asenapine transdermal + Tiotropium-olodaterol
Severity: Moderate
Asenapine transdermal and Tiotropium-olodaterol: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Asenapine can prolong the QT interval, and beta2-agonists may add to cardiac excitability and lower potassium. Together they may increase the risk of ventricular arrhythmias in susceptible patients. The risk with inhaled olodaterol at labeled doses is generally modest.
What this interaction means in plain words
Asenapine transdermal and Tiotropium-olodaterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive QT prolongation with beta2-mediated hypokalemia and cardiac stimulation.
What to do
Monitor ECG and serum potassium in patients with cardiac disease or other QT-prolonging drugs. Keep olodaterol at the labeled dose.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Asenapine transdermal and Tiotropium-olodaterol, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Tiotropium-olodaterol
Frequently asked questions
Can I take Asenapine transdermal with Tiotropium-olodaterol?
MediHelp rates the interaction as moderate. Asenapine transdermal and Tiotropium-olodaterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Asenapine can prolong the QT interval, and beta2-agonists may add to cardiac excitability and lower potassium. Together they may increase the risk of ventricular arrhythmias in susceptible patients. The risk with inhaled olodaterol at labeled doses is generally modest.
How serious is the interaction between Asenapine transdermal and Tiotropium-olodaterol?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and serum potassium in patients with cardiac disease or other QT-prolonging drugs. Keep olodaterol at the labeled dose.
What other medicines interact with Tiotropium-olodaterol?
MediHelp also lists interactions of Tiotropium-olodaterol with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Tiotropium-olodaterol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
